Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Other 1Breast 1

Conditions

Prostatic Neoplasms 2Weight Loss 1Obesity 1Lymphedema 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Weight Reduction Programs × Clear all
NCT03261271 2025-04-13

WARRIOR

University of Kansas Medical Center

Phase NA Completed
40 enrolled 19 charts
GenitourinaryOther

Obesity, Prostatic Neoplasms

NCT04974268 2025-02-14

EJERDIETLIF

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms, Lymphedema

NCT02252484 2016-09-07

Energy Balance for Prostate Cancer Survivorship

University of Kansas Medical Center

Phase NA Completed
20 enrolled
Genitourinary

Prostatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡